PHILADELPHIA, PA — QDx Pathology Services has announced its collaboration with Proscia®, a leading provider of digital and computational pathology solutions. By integrating Proscia’s advanced software into its operations, QDx aims to revolutionize the way its pathologists work, enabling them to diagnose diseases with greater speed and accuracy.
Digital pathology, which transforms traditional microscope slides into high-resolution digital images, is rapidly becoming the new standard in disease diagnosis. This technology allows for the examination of images that contain over 1 billion pixels, offering a detailed view of a patient’s disease pathology. The adoption of digital pathology is fueled by an expanding body of evidence supporting its benefits for routine laboratory operations, decision-making processes, and the integration of artificial intelligence (AI) to uncover new insights into diseases.
Pierre Mouawad, VP of Laboratory Operations at QDx Pathology Services, expressed the company’s commitment to leading the industry by adopting cutting-edge technologies. “Proscia’s software not only enhances our pathologists’ ability to perform their duties but also aligns with our goal of setting a new standard of excellence in pathology,” Mouawad stated. The implementation of Proscia’s software has already made a noticeable difference, streamlining collaboration among pathologists and improving the precision of diagnoses.
Proscia’s software is celebrated for its user-friendly design, comprehensive functionality, and scalability. These features are instrumental in driving productivity improvements and boosting confidence among pathologists as they navigate their daily tasks. Additionally, QDx Pathology Services is poised to further innovate by incorporating AI applications developed by Proscia, its customers, and partners within the Proscia Ready network.
David West, CEO of Proscia, commended QDx Pathology Services for its forward-thinking approach. “QDx demonstrates a profound understanding of what it takes to succeed in digital pathology, including fostering a culture of innovation and maintaining a dedication to both pathologists and patients,” said West. He expressed his confidence in QDx’s ability to fully leverage the advantages of digital pathology.
This partnership between QDx Pathology Services and Proscia marks a pivotal step in the evolution of pathology services. It highlights the growing trend towards digitalization in healthcare, promising more accurate and efficient diagnoses for patients. With recent advancements like the FDA 510(k) clearance for Proscia’s Concentriq® AP-Dx solution and the launch of the Proscia Ready partner alliance, the future of digital pathology looks brighter than ever, promising significant benefits for diagnostic laboratories and the broader medical community.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.